Valeant Plunges Anew On Report Of Possible Criminal Charges Against Former CEO, CFO

November 01, 2016   |   November 2016 Bond Updates
Valeant Pharmaceuticals plunged on Monday afternoon after Bloomberg News reported the company's former CEO J. Michael Pearson and CFO Howard Schiller may face criminal charges for accounting fraud.

View more at: http://www.forbes.com/sites/antoinegara/2016/10/31/valeant-plunges-anew-on-report-of-possible-criminal-charges-against-former-ceo-cfo/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/